Optas LLC’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $723K | Sell |
1,784
-150
| -8% | -$60.8K | 0.14% | 92 |
|
2025
Q1 | $962K | Buy |
1,934
+262
| +16% | +$130K | 0.17% | 66 |
|
2024
Q4 | $870K | Sell |
1,672
-232
| -12% | -$121K | 0.19% | 66 |
|
2024
Q3 | $1.18M | Buy |
1,904
+164
| +9% | +$101K | 0.27% | 53 |
|
2024
Q2 | $962K | Sell |
1,740
-320
| -16% | -$177K | 0.25% | 53 |
|
2024
Q1 | $1.2M | Sell |
2,060
-173
| -8% | -$101K | 0.33% | 48 |
|
2023
Q4 | $1.19M | Sell |
2,233
-158
| -7% | -$83.9K | 0.36% | 46 |
|
2023
Q3 | $1.21M | Buy |
2,391
+134
| +6% | +$67.8K | 0.4% | 43 |
|
2023
Q2 | $1.18M | Sell |
2,257
-19
| -0.8% | -$9.91K | 0.39% | 45 |
|
2023
Q1 | $1.31M | Buy |
2,276
+27
| +1% | +$15.6K | 0.47% | 43 |
|
2022
Q4 | $1.24M | Buy |
2,249
+10
| +0.4% | +$5.51K | 0.51% | 36 |
|
2022
Q3 | $1.14M | Sell |
2,239
-13
| -0.6% | -$6.6K | 0.5% | 37 |
|
2022
Q2 | $1.23M | Buy |
2,252
+784
| +53% | +$426K | 0.5% | 35 |
|
2022
Q1 | $868K | Buy |
1,468
+7
| +0.5% | +$4.14K | 0.28% | 56 |
|
2021
Q4 | $976K | Buy |
1,461
+1
| +0.1% | +$668 | 0.28% | 53 |
|
2021
Q3 | $834K | Buy |
1,460
+140
| +11% | +$80K | 0.24% | 56 |
|
2021
Q2 | $666K | Buy |
1,320
+17
| +1% | +$8.58K | 0.19% | 68 |
|
2021
Q1 | $595K | Buy |
1,303
+14
| +1% | +$6.39K | 0.19% | 75 |
|
2020
Q4 | $600K | Sell |
1,289
-415
| -24% | -$193K | 0.19% | 67 |
|
2020
Q3 | $752K | Buy |
1,704
+408
| +31% | +$180K | 0.23% | 73 |
|
2020
Q2 | $469K | Buy |
1,296
+299
| +30% | +$108K | 0.19% | 67 |
|
2020
Q1 | $282K | Buy |
997
+22
| +2% | +$6.22K | 0.14% | 98 |
|
2019
Q4 | $317K | Buy |
+975
| New | +$317K | 0.12% | 114 |
|